[nyschp.dop] Re: GP2B3A inhibitors & Stress Test Agents

From: Tom Lombardi <Thomas.Lombardi@xxxxxxxx>
To: "nyschp.dop@xxxxxxxxxxxxx" <nyschp.dop@xxxxxxxxxxxxx>
Date: Mon, 20 Jun 2016 14:59:00 +0000

Answers Below

***********************************************************************************************

Thomas P Lombardi, BS, PharmD, RPh, FASHP
System Director of Pharmacy
Chair, Institutional Review Board
O 518.525.1266    F 518.525.1917
Private Fax 518-944-2365
Thomas.lombardi@xxxxxxxx<mailto:Thomas.lombardi@xxxxxxxx>

St. Peter's Health Partners
315 S. Manning Blvd
Albany, New York 12208

[Description: Description: cid:image001.jpg@01CD6316.50EE3070]
For information about the PGY-1 Pharmacy Residency Program:
Website: www.sphcs.org/prp<http://www.sphcs.org/prp>

CONFIDENTIALITY NOTICE: This e-mail, including attachments, is for the sole
purpose of the individual to whom it is addressed, and may contain confidential
and privileged information.  Any unauthorized review , use, disclosure, or
distribution is prohibited.  If you have received this e-mail in error, please
notify the sender by reply e-mail and destroy this message and its attachments.

From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Tibi-Scherl, Leila
Sent: Monday, June 20, 2016 10:48 AM
To: 'nyschp.dop@xxxxxxxxxxxxx'
Subject: [nyschp.dop] GP2B3A inhibitors & Stress Test Agents

Good morning, all,

A member hospital would like feedback on your practices with GP2B3A inhibitors
and Stress Test Agents. Please respond YES or NO to the following two short
questions:

Is your hospital using to Aggrastat as the primary glycoprotein 2b/3a inhibitor
(as compared to Integrilin)? NO

Is your hospital using Lexiscan as the primary nuclear stress test agent? YES

Your time is greatly appreciated. Thank you in advance for taking the time to
respond!

Sincerely,
Leila
--
Leila M. Tibi-Scherl, Pharm.D.
VP, Pharmacy Practice
GNYHA Services, Inc. | 555 W. 57th Street, Suite 1156 | New York, NY 10019
* 212.259.0775 |È646.483.3333 |7 212.541.9032 |*
tibi@xxxxxxxxx<mailto:tibi@xxxxxxxxx>
www.pharmacy.gnyhaservices.com<http://www.pharmacy.gnyhaservices.com/>

PQ Please consider the environment before printing this email.

Confidentiality Notice:
This e-mail, including any attachments is the property of Trinity Health and is
intended for the sole use of the intended recipient(s). It may contain
information that is privileged and confidential.  Any unauthorized review, use,
disclosure, or distribution is prohibited. If you are not the intended
recipient, please delete this message, and reply to the sender regarding the
error in a separate email.

References:
- [nyschp.dop] GP2B3A inhibitors & Stress Test Agents
  - From: Tibi-Scherl, Leila

[nyschp.dop] Re: GP2B3A inhibitors & Stress Test Agents

Other related posts: